Brandinium

Trademark search for:

ALQELA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2022-06-16 — Application filed
  • 2022-06-20 — Application filed
  • 2022-07-05 — Application filed
  • 2023-02-15 — Assigned to examiner
  • 2023-02-21 — Approved for pub - principal register
  • 2023-03-08 — Notification of notice of publication e-mailed
  • 2023-03-28 — Published for opposition
  • 2023-03-28 — Official gazette publication confirmation e-mailed
  • 2023-05-23 — Noa e-mailed - sou required from applicant
  • 2023-11-24 — Sou extension 1 filed
  • 2023-12-25 — Application abandoned
  • 2023-12-26 — Application abandoned
  • 2024-01-04 — Teas petition to revive received
  • 2024-01-04 — Petition to revive-granted
  • 2024-01-04 — Notice of revival - e-mailed
  • 2024-01-04 — Sou extension received with teas petition
  • 2024-01-04 — Notice of revival - e-mailed
  • 2024-02-21 — Case assigned to intent to use paralegal
  • 2024-03-01 — Sou extension 1 granted
  • 2024-03-02 — Notice of approval of extension request e-mailed
  • 2024-04-30 — Sou teas extension received
  • 2024-04-30 — Sou extension 2 filed
  • 2024-04-30 — Sou extension 2 granted
  • 2024-05-01 — Notice of approval of extension request e-mailed
  • 2024-11-19 — Sou teas extension received
  • 2024-11-19 — Sou extension 3 filed
  • 2024-11-19 — Sou extension 3 granted
  • 2024-11-19 — Notice of approval of extension request e-mailed
  • 2025-05-14 — Sou teas extension received
  • 2025-05-14 — Sou extension 4 filed
  • 2025-05-14 — Sou extension 4 granted
  • 2025-05-15 — Notice of approval of extension request e-mailed
  • 2025-12-29 — Application abandoned
  • 2025-12-29 — Application abandoned
  • 2025-12-29 — Final status recorded

Owner Information

TEVA PHARMACEUTICALS USA, Inc.
Parsippany , NJ
TEVA PHARMACEUTICALS USA, Inc.
Parsippany , NJ

Correspondent

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
400 INTERPACE PARKWAY
BUILDING A
PARSIPPANY, NJ 07054

Filing Details

Filing Date:
2022-06-16
Status Date:
2025-12-29
Category:
Pharmaceuticals
Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.